# DyaMX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dyamx

- Industry: Pharmaceuticals
- Headquarters: Plymouth, US
- Total disclosed funding: $13M
- Latest round: Series A (Nov 30, 2018)
- Investors on record: 1

## About

Founded in 2017 and based in Minnesota, US, DyaMX, Inc. is a stealth healthcare company that develops therapeutics for the treatment of gastrointestinal and metabolic diseases.

## Funding rounds

- Series A, Nov 30, 2018, $13M — Sante Ventures

## Investors

- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Series A